🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with HBeAG positive, chronic HBV infection will receive either ARC...
Status
Terminated
Location
Research Site 1
Start Date
2015-11
Trial ID
NCT02604212
Treatments Being Tested
To determine the pharmacokinetics and bioequivalence of cetirizine hydrochl...
Status
Completed
Location
AAIPharma Inc.- AAI Clinic
Start Date
2006-08
Trial ID
NCT00863902
Treatments Being Tested
This study will assess the ability of montelukast to improve the signs and ...
Status
Completed
Location
Multiple Locations
Start Date
2001-11
Trial ID
NCT00974571
Treatments Being Tested
Ketotifen is an established antihistamine drug, widely used in pediatric cl...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00639587
Treatments Being Tested
To determine the pharmacokinetics and bioequivalence of cetirizine hydrochl...
Status
Completed
Location
AAIPharma Inc.- AAI Clinic
Start Date
2006-08
Trial ID
NCT00864279
Treatments Being Tested
This phase IV investigational trial is being conducted to evaluate the effi...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-01
Trial ID
NCT01916226
Treatments Being Tested
The primary objective of the study was to examine the efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01651871
Treatments Being Tested
This is a randomised, double-blind, placebo-controlled 4-period cross-over ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-01
Trial ID
NCT00972504
Treatments Being Tested
Double-blind, two-parallel-arm, placebo-controlled randomized clinical tria...
Status
Terminated
Location
IRCCS Istituto Giannina Gaslini
Start Date
2015-07
Trial ID
NCT02394106
Treatments Being Tested
A randomised, double-blind, placebo-controlled, 4-period incomplete block c...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09
Trial ID
NCT00851344
Treatments Being Tested